LETTER
Michael–Claisen Strategy for Cyclohexane-1,3-dione Derivative Synthesis
1203
Table 2 CDD Synthesis following CDMCC and CMCC Processes (continued)
Yield (%)a
Entry
13
Acetone derivatives
Unsaturated compounds
Product
Time (min)
O
O
CO2Et
40
69
O
21
O
O
CO2Et
14
15
60
60
66
64
O
22
CO2Et
OEt
O
O
O
CO2Et
OEt
O
O
23
a Isolated yields; reaction conditions: NaH, neat, –10 °C → r.t.
Chem. 2009, 74, 3211. (c) Weng, B.; Liu, R.; Li, J. H.
The reaction of acetone with ethyl 3-methylbut-2-enoate
(24) gave the unusual product, 25, in 45% yield (Scheme
5). The product 25 is only possible when a highly conju-
gated carbanion is generated at the C4 position of 24; sub-
sequent nucleophilic attack on acetone followed by
dehydration of the corresponding hydroxy intermediate
and hydrolysis of the ester leads to conjugated acid 25.
Synthesis 2010, 2926. (d) Ramachary, D. B.; Kishor, M.
J. Org. Chem. 2007, 72, 5056. (e) Kraus, G. A.; Wan, Z.
Synlett 2000, 363.
(3) (a) Pool, W. F.; Woolf, T. F.; Reily, M. D.; Caprathe, B. W.;
Emmerling, M. R.; Jean, J. C. J. Med. Chem. 1996, 39,
3014. (b) Han, Y.; Hou, H.; Yao, R.; Fu, Q.; Yan, C. G.
Synthesis 2010, 4061. (c) Vanejevs, M.; Jatzke, C.; Renner,
S.; Müller, S.; Hechenberger, M.; Bauer, T.; Klochkova, A.;
Pyatkin, I.; Kazyulkin, D.; Aksenova, E.; Shulepin, S.;
Timonina, O.; Haasis, A.; Gutcaits, A.; Parsons, C. G.;
Kauss, V.; Weil, T. J. Med. Chem. 2008, 51, 634.
(4) Beaudegnies, R.; Edmunds, A. J. F.; Fraser, T. E. M.; Hall,
R. G.; Hawkes, T. R.; Mitchell, G.; Schaetzer, J.;
Wendeborn, S.; Wibley, J. Bioorg. Med. Chem. 2009, 17,
4134.
(5) Rubinov, D. B.; Rubinova, I. L.; Akhrem, A. A. Chem. Rev.
1999, 99, 1047.
(6) Leonard, S. E.; Reddie, K. G.; Carroll, K. S. ACS Chem.
Biol. 2009, 4, 783.
(7) (a) Miller, J. J.; Benneville, P. L. J. Org. Chem. 1957, 22,
1268. (b) Celli, A. M.; Lampariello, L. R.; Chimichi, S.;
Nesi, R.; Scotton, M. Can. J. Chem. 1982, 60, 1327. (c) Im,
Y. J.; Lee, C. G.; Kim, H. R.; Kim, J. N. Tetrahedron Lett.
2003, 44, 2987.
In conclusion for the first time commercially available ac-
etone was used as starting material for CDD synthesis.
Through these studies, the existing problem of unreactive
acetone for CDD synthesis and scope of other ketones
were investigated successfully. Both solvent and neat
methods were developed for novel (1,13 14, 15 and 23) and
known classes of CDD synthesis following a highly re-
gioselective consecutive Michael–Claisen process. We
hope that, in the near future, this process will meet indus-
trial demand, and that novel molecules will attract more
interest for target-based design of natural and unnatural
bioactive molecules.
Acknowledgment
(8) (a) Foster, J. E.; Nicholson, J. M.; Butcher, R.; Stables, J. P.;
Edaogho, I. O.; Goodwin, A. M.; Henson, M. C.; Smith,
C. A.; Scott, K. R. Bioorg. Med. Chem. 1999, 7, 2415.
(b) Fadeyi, O. O.; Okoro, C. O. Tetrahedron Lett. 2008, 49,
4725.
Authors are grateful to Dr. P. S. Ahuja, Director IHBT (CSIR) for
providing necessary facilities during the course of the work. Finan-
cial assistance to D.S. (SRF), Bandna (SRF) and A.K.S. (JRF) from
CSIR, New Delhi, India is gratefully acknowledged.
(9) (a) Ishikawa, T.; Kadoya, R.; Arai, M.; Takahashi, H.; Kaisi,
Y.; Mizuta, T.; Yoshikai, K.; Saito, S. J. Org. Chem. 2001,
66, 8000. (b) Ishikawa, T.; Kudo, K.; Kuroyabu, K.; Uchida,
S.; Kudoh, T.; Saito, S. J. Org. Chem. 2008, 73, 7498.
(10) Das, P.; Sharma, D.; Singh, B. Int. Appl WO2011117881,
2011.
(11) Basu, B.; Das, P.; Hossain, I. Synlett 2004, 2224.
(12) (a) Juma, B.; Adeel, M.; Villinger, A.; Langer, P.; Reinke,
H.; Spannenberg, A.; Fischer, C.; Langera, P. Adv. Synth.
Catal. 2009, 351, 1073. (b) Poole, L. B.; Zeng, B. B.;
Supporting Information for this article is available online at
References and Notes
(1) IHBT communication no. 2181.
(2) (a) Takagi, R.; Miwa, Y.; Matsumura, S.; Ohkata, K. J. Org.
Chem. 2005, 70, 8587. (b) Zhao, Y. M.; Gu, P.; Zhang, H.
J.; Zhang, Q. W.; Fan, C. A.; Tu, Y. Q.; Zhang, F. M. J. Org.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2012, 23, 1199–1204